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In  this  issue  of  'EP  Update'  we  summarize  the  recent  literature  on 
arrhythmogenic right ventricular dysplasia (ARVD). The articles have been hand 
picked  and  reviewed  by  the  editors  of  IPEJ  for  the  benefit  of  readers.     
Electrocardiographic differentiation of arrhythmia due to ARVD from that 
arising from right ventricular outflow tract                                       
Ventricular  arrhythmias  due  to  ARVD  and  right  ventricular  outflow  tract 
arrhythmia  (RVOTA)  share  the  same  left  bundle  branch  block  pattern  with 
inferior axis on the ECG. The former has a more malignant course while the 
latter has a better prognosis and is more amenable to radiofrequency catheter 
ablation.  Hence  differentiating  them  is  of  utmost  clinical  importance  in  the 
management of these patients. QRS notching has been mentioned to be one of 
the differentiating features. Ren L and associates [1] studied electrocardiographic 
differentiation of  arrhythmias in ARVD from RVOTA and concluded that  in 
addition  to  QRS  notching  in  lateral  leads,  QRS  duration  in  lead  I  of  125 
milliseconds or more and a precordial R/S transition beyond V4 are useful in 
differentiation.  The differences are thought to be due to the patchy fibrofatty 
replacement  of  myocardial  tissue  in  ARVD  which  causes  slow  conduction, 
unlike in RVOTA with structurally normal heart. Authors claim better sensitivity 
and  specificity  by  increasing  the  cutoff  value  for  QRS  widening  from  120 
milliseconds  to  125  milliseconds.  QRS  notching  probably  has  similar 
significance  as  fragmented  QRS  described  by  other  authors [2]  in  different 
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conditions of structural heart disease and cardiac channelopathies.            
Usefulness of ECG for prediction of risk in ARVD                           
A  study  by  Saguner  AM  et  al  [2]  evaluated  111  patients  with  ARVD  to 
determine whether  ECG parameters  are  useful  in  prediction of  risk of  major 
adverse cardiac arrhythmic events in ARVD. The events evaluated were death 
due to cardiac cause, cardiac transplantation, resuscitated sudden cardiac death, 
ventricular  fibrillation,  sustained  ventricular  tachycardia  and  arrhythmic 
syncope. About half of their patients had one or more of these adverse cardiac 
events. They found that T wave inversion in inferior leads, fragmented QRS and 
a  precordial  QRS  amplitude  ratio  of  0.48  or  less  were  useful  predictors  of 
arrhythmic events in ARVD. Precordial QRS amplitude ratio was calculated as 
the ratio of sum of QRS amplitude in leads V1-V3 to sum of QRS amplitude in 
leads V1-V6. This was a long term observational study with a median follow up 
duration of 4.6 years. Other studies have linked inferior T wave inversions in 
ARVD to left ventricular involvement and hence the prognostic significance. T 
wave  inversion  in  more  than  three  precordial  leads  was  also  noted  to  be 
important  in  prediction  of  cardiac  events,  possibly  for  similar  reasons.  One 
important limitation noted by the authors is a relatively high event rate in their 
cohort possibly indicating a referral bias towards more advanced cases. Hence 
the applicability of the results to a low risk cohort may not be good.         
Role of beta adrenergic stimulation in diagnosis of ARVD                                
Denis  A  and  colleagues  tested  the  value  of  beta  adrenergic  stimulation  by 
isoproterenol  infusion in  over  four  hundred patients  referred with ventricular 
premature complexes  or  suspected  arrhythmogenic  right  ventricular  dysplasia 
(ARVD)  [3].  Test  was  considered  positive  if  either  polymorphic  ventricular 
premature complexes with at least one couplet or ventricular tachycardia of left 
bundle branch block pattern other than right ventricular outflow tract tachycardia 
was  induced  by  isoproterenol  infusion.  Isoproterenol  infusion  given  at  45 
microgram per minute for three minutes had a high negative predictive value of 
99.1%.  But  the  positive  predictive  value  was  low at  43.2%.  Sensitivity  and 
specificity of the test was good at 91.4% and 88.9% respectively. It is interesting 
to note that 6 patients who did not have features of ARVD at initial evaluation 
developed features satisfying the diagnostic criteria during a mean follow up of 
5.6 years. All six of them had positive isoproterenol test at the initial evaluation 
itself, thus giving some role in future prediction as well!                                
An accompanying editorial by Calkins H et al [4] cautions us that high dose 
isoproterenol  infusion  is  not  without  risks  as  there  is  chance  of  arrhythmia 
induction  and  hypotension.  They  suggest  that  it  should  be  reserved  for  a 
controlled  setting  as  in  an  electrophysiology  laboratory  during  an  invasive 
electrophysiological  study  rather  than  just   in  a  monitored  floor.          
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Role of serial evaluation of at risk family members of ARVD                       
It is well accepted that family members of patients with ARVD need screening 
for the disease. But the need of longitudinal follow up of at risk family members 
is not well established. te Riele AS and associates [5] checked the role of serial 
screening of at risk family members. They evaluated all first degree relatives in 
case  of  mutation  negative  probands  and  all  mutation  carriers  among  family 
members  of  mutation  positive  probands.  92%  of  mutation  carriers  had  a 
plakophilin-2  mutation.  Study  cohort  comprised  of  117  relatives  from  64 
families  who  had  undergone  ECG  and  cardiac  magnetic  resonance  imaging. 
Thirty seven percent of the study cohort were diagnosed as having ARVD at first 
evaluation itself. Those without ARVD at initial evaluation were followed up for 
a mean period of 4.1 years.  Thirty seven patients had complete re-evaluation 
including cardiac magnetic resonance imaging. Authors concluded that electrical 
progression is seen in one third of the at risk relatives and structural progression 
of  the  disease  is  rare.  They  also  noted  that  electrical  abnormalities  precede 
detection of structural abnormalities, which is quite acceptable considering the 
fact  that  ARVD is  predominantly an electrical  disorder  of  the  heart.        
Marcus F et al [6] in an editorial comment of the study notes that though 50% of 
first degree relatives of an ARVD patient is likely to have the mutation, there is 
no  strong  association  between  mutation  carriage  and  the  phenotypic  disease 
manifestation.  Though  11  genes  related  ARVD  are  known,  majority  of  the 
mutations are in 5 desmosomal genes. Genetic testing of first degree relatives is 
done only if a mutation is detected in the proband, which is the situation in 30-
50% of the cases. As sudden death in ARVD is rare before the age of ten years, 
serial  evaluation  probably  is  not  needed  before  that  age,  or  at  least  cardiac 
magnetic resonance imaging can be deferred in those without any abnormality 
on the ECG. Close follow up for electrical progression which predates structural 
changes is needed in all relatives at risk of the disease.                                  
Data from the North American ARVD registry                               
North American ARVD registry is a multidisciplinary study on various aspects 
of ARVD and data from 137 patients enrolled in the study has been published 
[7]. One hundred and eight patients in the registry have received an implantable 
cardioverter  defibrillator  (ICD).  The observations suggest  that  antitachycardia 
pacing (ATP) is quite successful in terminating ventricular tachycardia in ARVD 
and  that  it  should  be  programmed  in  all  cases,  even  for  fast  ventricular 
tachycardia. It was also documented that majority of the ventricular arrhythmias 
are  monomorphic,  thus  explaining  the  high  success  rate  of  ATP.  T  wave 
inversion in inferior leads and spontaneous ventricular arrhythmias at enrollment 
predicted ventricular arrhythmias on follow up. It may be noted that the same 
observation was also documented by Saguner AM et al [2].   Only predictor of 
life  threatening ventricular  arrhythmia  was  young age  at  enrollment.        
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